Tune in to the next episode of the GOLD podcast to hear the team's latest conversation with a leading figure in the pharmaceutical industry. What is being discussed this week? The industry's evolving commercial model. In this week's episode, Isabel chats with Chetak Buaria, Vice President of Global Commercial Operations, Oncology, Merck Group, about how a new model driven by technology and data is in sight. The two explore what this new model might look like, whether pharma is ready for it and how to move forward without alienating internal or external stakeholders. The opinions and views expressed here are his personal and do not necessarily reflect the opinions or views of Merck Healthcare KGaA, Germany or any subsidiary thereof. If you're interested in learning more about the topic areas discussed in this episode, check out the following content:

• Tipping the scales of KOL success
• Conquering generational differences in HCP marketing
• Is the pharma rep at death's door?
• Last week's episode: Getting to grips with customer experience